{"id":"W4389899921","doi":"10.1097/hep.0000000000000726","title":"Adjuvant and neoadjuvant therapies for hepatocellular carcinoma","year":2023,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre; Toronto General Hospital","funders":"","keywords":"Medicine; Oncology; Sorafenib; Adjuvant; Internal medicine; Clinical trial; Atezolizumab; Bevacizumab; Clinical endpoint; Adjuvant therapy; Hepatocellular carcinoma; Cancer; Immunotherapy; Nivolumab; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006517809,0.00025758,0.000788908,0.0009353675,0.0001292372,0.00049369,0.0002033329,0.0002990467,0.002093088],"category_scores_gemma":[0.0006661926,0.00008765433,0.0005065792,0.0008143659,0.0002104558,0.0003784876,0.0002908788,0.0006223544,0.0005317706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002810696,"about_ca_system_score_gemma":0.0005715224,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003867038,"about_ca_topic_score_gemma":0.001653816,"domain_scores_codex":[0.9998189,0.00006330923,0.00004021708,0.00001851183,0.00004550357,0.00001366761],"domain_scores_gemma":[0.9997213,0.0001540089,0.0000607824,0.000007636012,0.00004091961,0.00001533028],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001949797,0.00007106461,0.0004825867,0.01526383,0.0001750808,0.0001613914,0.00003791967,0.0002022345,0.001292382,0.001075514,0.007749088,0.9732939],"study_design_scores_gemma":[0.0002410014,0.000903347,0.009380585,0.01826346,0.001082196,0.003242462,0.0001318275,0.0002886446,0.002073416,0.00263928,0.9617099,0.0000438854],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005897737,0.9981197,0.0001109742,0.0002549575,0.00009262047,0.000006577939,0.00001909991,0.000003394918,0.0008029655],"genre_scores_gemma":[0.006348255,0.9924368,0.0002566872,0.0002631049,0.0002185612,0.00001713154,0.00006092595,0.00000178969,0.0003966963],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002093088,"threshold_uncertainty_score":0.007002056,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07839865103530189,"score_gpt":0.276469474019007,"score_spread":0.1980708229837051,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}